Related references
Note: Only part of the references are listed.Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases
Leela Rani Avula et al.
MOLECULAR CANCER RESEARCH (2020)
Prognostic significance of mesothelin expression in colorectal cancer disclosed by area-specific four-point tissue microarrays
Takehiro Shiraishi et al.
VIRCHOWS ARCHIV (2020)
Diffuse mesothelin expression leads to worse prognosis through enhanced cellular proliferation in colorectal cancer
Satoshi Inoue et al.
ONCOLOGY LETTERS (2020)
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic
Takahiro Tsujikawa et al.
CLINICAL CANCER RESEARCH (2020)
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors
Raffit Hassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mesothelin Expression in Patients with High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome But Correlates with CD11c+Expression in Tumor
Isabelle Magalhaes et al.
ADVANCES IN THERAPY (2020)
Favorable therapeutic response after anti-Mesothelin antibody-drug conjugate treatment requires high expression of Mesothelin in tumor cells
Lea Lazzerini et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin
Raffit Hassan et al.
CANCER (2020)
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models
Qun Jiang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal-type breast cancer
Takafumi Suzuki et al.
ONCOLOGY LETTERS (2020)
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
Kai Le et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer
Su-Jin Shin et al.
ONCOLOGIST (2019)
Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2019)
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
Andrew R. Haas et al.
MOLECULAR THERAPY (2019)
Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer
Orgilmaa Regzedmaa et al.
ONCOTARGETS AND THERAPY (2019)
Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study
Christopher B. Nahm et al.
EJSO (2019)
Update of the FANTOM web resource: expansion to provide additional transcriptome atlases
Marina Lizio et al.
NUCLEIC ACIDS RESEARCH (2019)
Mesothelin expression has prognostic value in stage / colorectal cancer
Takehiro Shiraishi et al.
VIRCHOWS ARCHIV (2019)
Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications
Fabien Forest et al.
PATHOLOGY (2018)
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
Tatsuzo Mizukami et al.
Oncotarget (2018)
Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors
Salma El-Behaedi et al.
TOXINS (2018)
Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative Zr-89-ImmunoPET
Anton G. T. Terwisscha van Scheltinga et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Mesothelin promotes epithelial-tomesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells
Xiaoqing He et al.
MOLECULAR CANCER (2017)
Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy
Tatsuya Hanaoka et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
Shingo Inaguma et al.
ONCOTARGET (2017)
Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1
Takashi Eguchi et al.
ONCOTARGET (2017)
Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes
Song-Hee Han et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Colin D. Weekes et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy
Frieder Bauss et al.
MOLECULAR ONCOLOGY (2016)
Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis
Abd AlRahman Mohammad Foda et al.
PATHOLOGY & ONCOLOGY RESEARCH (2016)
Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis
Doaa Abdelaziz Ibrahim et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy
Peter B. Illei et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)
Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers
Ibrahim Vedat Bayoglu et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
Anish Thomas et al.
ONCOTARGET (2015)
Gateways to the FANTOM5 promoter level mammalian expression atlas
Marina Lizio et al.
GENOME BIOLOGY (2015)
Mesothelin Expression in Pancreatic Mucinous Cysts
Renee Frank et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Mesothelin expression is associated with poor outcomes in breast cancer
Yun R. Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Phase II Clinical Trial of Amatuximab, a Chimeric Antimesothelin Antibody with Pemetrexed and Cisplatin in Advanced Unresectable Pleural Mesothelioma
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2014)
The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration
Daniel C. Dim et al.
DIAGNOSTIC CYTOPATHOLOGY (2014)
Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study
Nelson G. Ordonez et al.
HUMAN PATHOLOGY (2014)
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma
Futoshi Kawamata et al.
JOURNAL OF GASTROENTEROLOGY (2014)
An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
Suzie J. Scales et al.
MOLECULAR CANCER THERAPEUTICS (2014)
ERC/mesothelin is expressed in human gastric cancer tissues and cell lines
Tomoaki Ito et al.
ONCOLOGY REPORTS (2014)
Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer
Napa Parinyanitikul et al.
CLINICAL BREAST CANCER (2013)
Mesothelin Expression Is a Prognostic Factor in Cholangiocellular Carcinoma
Ryohei Nomura et al.
INTERNATIONAL SURGERY (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Novel Immunocytokine IL12-SS1 (Fv) Inhibits Mesothelioma Tumor Growth in Nude Mice
Heungnam Kim et al.
PLOS ONE (2013)
Mesothelin Binding to CA125/MUC16 Promotes Pancreatic Cancer Cell Motility and Invasion via MMP-7 Activation
Shih-Hsun Chen et al.
SCIENTIFIC REPORTS (2013)
Reevaluation and Identification of the Best Immunohistochemical Panel (pVHL, Maspin, S100P, IMP-3) for Ductal Adenocarcinoma of the Pancreas
Haiyan Liu et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways
Ming-Cheng Chang et al.
BIOCHEMICAL JOURNAL (2012)
Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer
T. Einama et al.
BRITISH JOURNAL OF CANCER (2012)
Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal Adenocarcinoma
Nabil P. Rizk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Mesothelin Overexpression Promotes Mesothelioma Cell Invasion and MMP-9 Secretion in an Orthotopic Mouse Model and in Epithelioid Pleural Mesothelioma Patients
Elliot L. Servais et al.
CLINICAL CANCER RESEARCH (2012)
Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer
Futoshi Kawamata et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway
Chunning Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Mesothelin Promotes Invasion and Metastasis in Breast Cancer Cells
Y. Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Clinicopathological Significance of Mesothelin Expression in Invasive Breast Cancer
L. Wang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Mesothelin expression correlates with prolonged patient survival in gastric cancer
Kenji Baba et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor
Evripidis Lanitis et al.
MOLECULAR THERAPY (2012)
Mesothelin as a Potential Therapeutic Target in Human Cholangiocarcinoma
Liping Yu et al.
Journal of Cancer (2012)
Mesothelin and GPR30 Staining Among a Spectrum of Pancreatic Epithelial Neoplasms
Joseph P. Glass et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2011)
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression
Uddalak Bharadwaj et al.
MOLECULAR CANCER (2011)
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma
Takahiro Einama et al.
PANCREAS (2011)
Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
Raffit Hassan et al.
CLINICAL CANCER RESEARCH (2010)
Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoter
Ke Tan et al.
HUMAN PATHOLOGY (2010)
Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
Ali Dastranj Tabrizi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway
Ming-Cheng Chang et al.
BIOCHEMICAL JOURNAL (2009)
Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
Robert J. Kreitman et al.
CLINICAL CANCER RESEARCH (2009)
A Binding Domain on Mesothelin for CA125/MUC16
Osamu Kaneko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Guide to the Perplexed on the Specificity of Antibodies
Clifford B. Saper
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells
Shayna L. Showalter et al.
CANCER BIOLOGY & THERAPY (2008)
Distinguishing breast carcinoma from Mullerian serous carcinoma with mammaglobin and mesothelin
William A. Kanner et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells
Norihisa Uehara et al.
MOLECULAR CANCER RESEARCH (2008)
Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy
Hector Alvarez et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions
Robert T. Pu et al.
DIAGNOSTIC CYTOPATHOLOGY (2008)
Diagnostic value of cytokeratin 7, CD10 and mesothelin in distinguishing ovarian clear cell carcinoma from metastasis of renal clear cell carcinoma
X. Leroy et al.
HISTOPATHOLOGY (2007)
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma
Louis A. Dainty et al.
GYNECOLOGIC ONCOLOGY (2007)
Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
Kei Kushitani et al.
PATHOLOGY INTERNATIONAL (2007)
S-100A4 protein and mesothelin expression in dysplasia and carcinoma of the extrahepatic bile duct
Huicong Zhao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
Jennifer A. A. Gubbels et al.
MOLECULAR CANCER (2006)
Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates - A translational research application
Nirag Jhala et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies
ML Galloway et al.
HISTOPATHOLOGY (2006)
The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung:: a comparative study
NG Ordóñez
MODERN PATHOLOGY (2006)
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma
MJ Yen et al.
CLINICAL CANCER RESEARCH (2006)
Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis
R Hassan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Localization of mesothelin in epithelial ovarian cancer
R Hassan et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
Forced expression of ΔN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin
B Liebig et al.
CANCER LETTERS (2005)
Markers of adenocarcinoma characteristic of the site of origin: Development of a diagnostic algorithm
JL Dennis et al.
CLINICAL CANCER RESEARCH (2005)
Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays
SL Swierczynski et al.
HUMAN PATHOLOGY (2004)
Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia
R Drapkin et al.
HUMAN PATHOLOGY (2004)
Gene expression profiling identifies markers of ampullary adenocarcinorna
NT Van Heek et al.
CANCER BIOLOGY & THERAPY (2004)
The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma:: A comparative study
NG Ordóñez
HUMAN PATHOLOGY (2004)
The immunohistochemical diagnosis of mesothelioma -: A comparative study of epithelioid mesothelioma and lung adenocarcinoma
NG Ordóñez
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas
HF Frierson et al.
HUMAN PATHOLOGY (2003)
Value of mesothelin immunostaining in the diagnosis of mesothelioma
NG Ordóñez
MODERN PATHOLOGY (2003)
Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types - An immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura
M Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Application of mesothelin immunostaining in tumor diagnosis
NG Ordonez
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma
CC Pan et al.
HUMAN PATHOLOGY (2003)
Mesothelin is not required for normal mouse development or reproduction
TK Bera et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
